SlideShare a Scribd company logo
CASE PRESENTATION
Nguyen Duc Thang, MD
CHIEF COMPLAINT
A 22-year-old male patient presented to hospital because of his
SOB
DISCUSSION
What additional information would you like to know?
HISTORY OF PRESENT ILLNESS
• Onset: 5 days prior to admission
• Characteristic: both inhale and exhale, gradually progressive SOB
• Exacerbating: Exertional, when pt have mild excertion
• Relieving factor: take a rest
• Associated symptoms:
• No cough
• No chest pain
• Edema at both leg, fever 2 day resolved itself before edema happened
Shortness of breath
HISTORY
1. PMH: unremarkable
2. PSH: unremarkable
3. medication: None
4. Allergies: No allergic history
5. Social history: sexually active, No traveling recently, no alcohol intake, no
smoking
6. Family history: unremarkable
DISCUSSION
On physical examination, what do you expect to find?
PHYSICAL EXAMINATION
• General status: alert and full of awareness, oriented x 3, No distress, no rash, BMI 21
• VS: Temp: 37 degree Celcius, HR: 115 bpm, BP: 130/75 mmHg, RR: 20 , SpO2 95-96% ambient air
• HEENT: no abnormalities
• CV: RRR, muffled heart sound ; systolic murmurs at 4th intercostal space left sternal edge, no rubs,
or gallops, no jugular distention
• Lungs: no wheezes, no rale, clear to percussion bilaterally, normal tactile fremitus.
• Abdomen: no distention, soft, no tenderness.
• Other organ : unremarkable finding
ONE LINER
What’s your one liner?
ONE LINER
A 22-years-old male patient with normal history presented to hospital because of
his exertional SOB after 2 days of fever. On PE, he had edema and systolic
murmur at mitral valve.
DISCUSSION
What is your differential diagnosis?
DISCUSSION
What tests would you like to order?
LABORATORY AND IMAGING TEST
CBC
RBC 5.27
Hgb 162 g/L
Hct 0.39
MCV 84 fL
MCH 31 pg
WBC 9.05
NEU 5.65 (62.4%)
LYM 2.53 (28%)
PLT 275 G/L
Biochem – Electrolyte - Coagulation
Natri 136.3 mmol/L
Kali 3.4 mmol/L
Clo 101 mmol/L
Glucose 4.7 mmol/L
CRP 1.9
ure 7.4
Tropoin Ths 422
NT-proBNP 6805
creatinin 71
AST 160
ALT 183
ABG
Ph 7.5
HCO3 26.5
pCO2 34
PO2
Sa O2
Lactate
83
97%
1.4
IMAGING
Chest Xray
ECHOCARDIOGRAPHY
• Pericardial effusion (7mm)
• LV: Globally hypokinetic, dilation, EF 20%
• Moderate mitral valve regurgitation
• Mild aortic valve regurgitation
• Mild pulmonary hypertension
• Pleural effusion with small amount of fluid
FINAL DIAGNOSIS
Acute Heart Failure/ Acute Myocarditis
Etiology of myocarditis
Infectious causes Noninfectious causes
Viral Spirochetal Cardiotoxins
•Adenovirus
•Arbovirus
•Coxsackie B virus
•Cytomegalovirus
•Dengue
•Echovirus
•Epstein-Barr virus
•Hepatitis B and C
•Herpesvirus
•HIV
•Influenza A and B
•Mumps
•Parvovirus
•Poliomyelitis
•Rabies
•Rubella
•Rubeola
•Vaccinia (smallpox vaccine)
•Varicella
•Variola
•Yellow fever
•Leptospirosis
•Lyme disease
•Relapsing fever
•Syphilis
•Alcohol
•Anthracyclines
•Arsenic
•Carbon monoxide
•Catecholamines
•Cocaine
•Cyclophosphamide
•Heavy metals (copper, lead, iron)
•Radiation
Mycotic
•Aspergillosis
•Blastomycosis
•Candidiasis
•Coccidioidomycosis
•Cryptococcosis
•Histoplasmosis
•Mucormycosis
•Sporotrichosis
Rickettsial Hypersensitivity reactions
•Q fever
•Rocky mountain spotted fever
•Typhus
•Antibiotics (penicillins, cephalosporins, sulfonamides)
•Clozapine
•Diuretics (thiazide, loop)
•Dobutamine
•Insect bites (bee, wasp, spider, scorpion)
•Lithium
•Methyldopa
•Snake bites
•Tetanus toxoid
•Vaccinations (eg, vaccinia, coronavirus mRNA vaccines)
Bacterial Protozoal Systemic disorders
•Actinomycosis
•Bartonella
•Brucellosis
•Chlamydia
•Cholera
•Clostridial
•Diphtheria
•Gonococcal
•Haemophilus
•Legionella
•Meningococcal
•Mycoplasma
•Nocardia
•Pneumococcal
•Psittacosis
•Salmonella
•Staphylococcal
•Streptococcal
•Tetanus
•Tuberculosis
•Tularemia
•Amebiasis
•Chagas disease (South American trypanosomiasis)
•Leishmaniasis
•Malaria
•Sleeping sickness (African trypanosomiasis)
•Toxoplasmosis •Celiac disease
•Collagen-vascular diseases
•Granulomatosis with polyangiitis
•Hypereosinophilia
•Inflammatory bowel disease (Crohn disease, ulcerative colitis)
•Kawasaki disease
•Sarcoidosis
•Thyrotoxicosis
Helminthic
•Ascariasis
•Echinococcosis
•Filariasis
•Paragonimiasis
•Schistosomiasis
•Strongyloidiasis
•Trichinosis
Uptodate
CLINICAL PRESENTATION
• history of recent upper respiratory infection or enteritis
• Excessive fatigue or exercise intolerance
• Chest pain
• Unexplained sinus tachycardia
• S3, S4, or summation gallop
• Atrial or ventricular arrhythmia
• New-onset or worsening heart failure
• Acute pericarditis
• Sudden cardiac death
• Respiratory distress/tachypnea
• Hepatomegaly uptodate
CLASSIFICATION
uptodate
Acute
myocarditis
Acute
coronary
syndrome-
like
New onset or
worsening HF
Life-
threatening
condition
Chronic
myocarditis
Chronic active
myocarditis
Chronic
persistent
myocarditis
ECG
UPTODATE
• ST changes
• Single atrial or ventricular ectopic beats,
• complex ventricular arrhythmias (couplets or nonsustained ventricular
tachycardia),
• atrial tachycardia or AF
Endomyocardial Biopsy
Histology + immunohistochemical stains (Dallas criteria): Gold
standard -Definitive diagnosis of myocarditis
uptodate
Endomyocardial Biopsy
EMB is recommended in the following settings:
• unexplained fulminant HF
• Unexplained new onset HF (2weeks-3 months) associated with a dilated
LV and new ventricular arrhythmias, Mobitz type II second-degree AV
block, third-degree AV block, or failure to respond to usual care within
one to two weeks
uptodate
Endomyocardial Biopsy
EMB is suggested in the following settings (when other evaluation is
inconclusive):
• HF of >3 months duration associated with dilated LV and new
ventricular arrhythmias, second or third degree AV block, or failure to
respond to usual care within one or two weeks
• HF associated with dilated cardiomyopathy associated with suspected
allergic reaction and/or eosinophilia.
• Other specific clinical settings when other evaluation is inconclusive
and diagnosis may impact treatment or prognosis
uptodate
Endomyocardial Biopsy
https://epos.myesr.org/posterimage/esr/ecr2009/40189/mediagallery/271123
“Clinically suspected myocarditis ” CRITERIA
clinical presentation + noninvasive diagnostic findings abnormalities
(CMR)
uptodate
identify patients who may be
candidates for EMB
- patients who do not have one
indication for EMB
- undergone EMB with
nondiagnostic results
WHEN TO APPLY
CRITERIA
Cardiovascular magnetic resonance (CMR)
https://www.jacc.org/doi/10.1016/j.jacc.2021.01.043
PCR and immunohistochemistry
• "immunohistochemical criteria”: ≥14 leukocytes/mm2, including up to
4 monocytes/mm2 with the presence of CD3-positive T-lymphocytes
≥7 cells/mm2
• enteroviral genomes in the myocardium of HF patients were a
biomarker of worse outcomes
• persistence of viral genome by PCR was associated with progressive
LV dysfunction, while clearance of viral genome was associated with
improved LV function
uptodate
Management
uptodate
• Heart failure therapy
• Therapy for arrhythmias
GENERAL
MANAGEMENT
• Therapy for arrhythmias
• Giant cell myocarditis
• Eosinophilic myocarditis
• Cardiac sarcoidosis
• Treatment of non-viral infections
• Celiac disease
MANAGEMENT
OF SPECIFIC
DISORDERS
TEACHING POINT
• Suspect Myocarditis in patients with or without cardiac signs and
symptoms , raised cardiac biomarkers, ECG changes suggestive of
acute myocardial injury, arrhythmia, global/regional abnormalities of
LV systolic function, particularly clinical findings are new and
unexplained
• Gold standard: EBM histology (Dallas criteria) +immunohistochemical
stains
• criteria for clinically suspected myocarditis: identify candidate for
EBM or provide a clinical diagnosis for patients who do not have one
indication for EMB
Thank you for listening
WHEN TO SUSPECT MYOCARDITIS?

More Related Content

Similar to 231115 Myocarditis - Duc Thhhang Y2.pptx

Preoperative preparations part 1
Preoperative preparations part 1Preoperative preparations part 1
Preoperative preparations part 1
Piyush Giri
 
OSCE FOR DNB.pptx
OSCE FOR DNB.pptxOSCE FOR DNB.pptx
OSCE FOR DNB.pptx
DileepRedemption
 
A case report of acute pancrititis
A case report of acute pancrititisA case report of acute pancrititis
A case report of acute pancrititis
Hao-Chen Ke
 
EMERGENCY RED FLAGS
EMERGENCY RED FLAGSEMERGENCY RED FLAGS
EMERGENCY RED FLAGS
Magdy Khames Aly
 
cerebrovenous thrombosis
cerebrovenous thrombosiscerebrovenous thrombosis
cerebrovenous thrombosis
Best Doctors
 
Polycythemia vera+ Myelofibrosis
Polycythemia vera+ MyelofibrosisPolycythemia vera+ Myelofibrosis
Polycythemia vera+ Myelofibrosis
憶 楊
 
Preoperative evaluation
Preoperative evaluationPreoperative evaluation
Preoperative evaluation
Richa Kumar
 
Extra hepatic manifestation of hep C
Extra hepatic manifestation of hep CExtra hepatic manifestation of hep C
Extra hepatic manifestation of hep C
Dr. Mishal Saleem
 
HTN EMERGENCIES AND URGENCIES
HTN EMERGENCIES AND URGENCIESHTN EMERGENCIES AND URGENCIES
HTN EMERGENCIES AND URGENCIES
Praveen Nagula
 
Endocarditis - Interesting Case Presentation
Endocarditis - Interesting Case PresentationEndocarditis - Interesting Case Presentation
Endocarditis - Interesting Case Presentation
Dr. Nagu Penakacherla
 
Celiac common presentation of a uncommon disease saved with date
Celiac common presentation of a uncommon disease  saved with dateCeliac common presentation of a uncommon disease  saved with date
Celiac common presentation of a uncommon disease saved with date
Muhammad Arshad
 
final.pptx
final.pptxfinal.pptx
final.pptx
gouthamvalapala31
 
Management of diastolic heart failure
Management of diastolic heart failureManagement of diastolic heart failure
Management of diastolic heart failure
Choying Chen
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
Mohamad Yaakub
 
Preventable ICU admissions at community level - Interactive Cases
Preventable ICU admissions at community level - Interactive CasesPreventable ICU admissions at community level - Interactive Cases
Preventable ICU admissions at community level - Interactive Cases
Vitrag Shah
 
Chf
ChfChf
Critical care medicine brenner
Critical care medicine brennerCritical care medicine brenner
Critical care medicine brenner
Adarsh
 
Interesting Case of Rowells syndrome
Interesting Case of Rowells syndromeInteresting Case of Rowells syndrome
Interesting Case of Rowells syndrome
Ramaiah Medical College
 
Pheochromocytoma radiology
Pheochromocytoma radiologyPheochromocytoma radiology
Pheochromocytoma radiology
Jayanth Hiremagalur
 
Adrenocortical insufficiency case study .pptx
Adrenocortical insufficiency case study .pptxAdrenocortical insufficiency case study .pptx
Adrenocortical insufficiency case study .pptx
nm97whd
 

Similar to 231115 Myocarditis - Duc Thhhang Y2.pptx (20)

Preoperative preparations part 1
Preoperative preparations part 1Preoperative preparations part 1
Preoperative preparations part 1
 
OSCE FOR DNB.pptx
OSCE FOR DNB.pptxOSCE FOR DNB.pptx
OSCE FOR DNB.pptx
 
A case report of acute pancrititis
A case report of acute pancrititisA case report of acute pancrititis
A case report of acute pancrititis
 
EMERGENCY RED FLAGS
EMERGENCY RED FLAGSEMERGENCY RED FLAGS
EMERGENCY RED FLAGS
 
cerebrovenous thrombosis
cerebrovenous thrombosiscerebrovenous thrombosis
cerebrovenous thrombosis
 
Polycythemia vera+ Myelofibrosis
Polycythemia vera+ MyelofibrosisPolycythemia vera+ Myelofibrosis
Polycythemia vera+ Myelofibrosis
 
Preoperative evaluation
Preoperative evaluationPreoperative evaluation
Preoperative evaluation
 
Extra hepatic manifestation of hep C
Extra hepatic manifestation of hep CExtra hepatic manifestation of hep C
Extra hepatic manifestation of hep C
 
HTN EMERGENCIES AND URGENCIES
HTN EMERGENCIES AND URGENCIESHTN EMERGENCIES AND URGENCIES
HTN EMERGENCIES AND URGENCIES
 
Endocarditis - Interesting Case Presentation
Endocarditis - Interesting Case PresentationEndocarditis - Interesting Case Presentation
Endocarditis - Interesting Case Presentation
 
Celiac common presentation of a uncommon disease saved with date
Celiac common presentation of a uncommon disease  saved with dateCeliac common presentation of a uncommon disease  saved with date
Celiac common presentation of a uncommon disease saved with date
 
final.pptx
final.pptxfinal.pptx
final.pptx
 
Management of diastolic heart failure
Management of diastolic heart failureManagement of diastolic heart failure
Management of diastolic heart failure
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Preventable ICU admissions at community level - Interactive Cases
Preventable ICU admissions at community level - Interactive CasesPreventable ICU admissions at community level - Interactive Cases
Preventable ICU admissions at community level - Interactive Cases
 
Chf
ChfChf
Chf
 
Critical care medicine brenner
Critical care medicine brennerCritical care medicine brenner
Critical care medicine brenner
 
Interesting Case of Rowells syndrome
Interesting Case of Rowells syndromeInteresting Case of Rowells syndrome
Interesting Case of Rowells syndrome
 
Pheochromocytoma radiology
Pheochromocytoma radiologyPheochromocytoma radiology
Pheochromocytoma radiology
 
Adrenocortical insufficiency case study .pptx
Adrenocortical insufficiency case study .pptxAdrenocortical insufficiency case study .pptx
Adrenocortical insufficiency case study .pptx
 

More from MyThaoAiDoan

Chuyen de ung thuuuuuuuuuuuuuuuuuuuuuu.ppt
Chuyen de ung thuuuuuuuuuuuuuuuuuuuuuu.pptChuyen de ung thuuuuuuuuuuuuuuuuuuuuuu.ppt
Chuyen de ung thuuuuuuuuuuuuuuuuuuuuuu.ppt
MyThaoAiDoan
 
Hoi chung lam sang benh ly gannnnnnn mat.ppt
Hoi chung lam sang benh ly gannnnnnn mat.pptHoi chung lam sang benh ly gannnnnnn mat.ppt
Hoi chung lam sang benh ly gannnnnnn mat.ppt
MyThaoAiDoan
 
CHƯƠNG-TRÌNH-THỰC-TẬP-NHI-NĂM-THỨ-6-ĐỢT-1-2019-BV-NHI-ĐỒNG-2 (1).ppt
CHƯƠNG-TRÌNH-THỰC-TẬP-NHI-NĂM-THỨ-6-ĐỢT-1-2019-BV-NHI-ĐỒNG-2 (1).pptCHƯƠNG-TRÌNH-THỰC-TẬP-NHI-NĂM-THỨ-6-ĐỢT-1-2019-BV-NHI-ĐỒNG-2 (1).ppt
CHƯƠNG-TRÌNH-THỰC-TẬP-NHI-NĂM-THỨ-6-ĐỢT-1-2019-BV-NHI-ĐỒNG-2 (1).ppt
MyThaoAiDoan
 
asd (NXPowerLLLLLLLLLLLLLLLLLLLLLite).ppt
asd (NXPowerLLLLLLLLLLLLLLLLLLLLLite).pptasd (NXPowerLLLLLLLLLLLLLLLLLLLLLite).ppt
asd (NXPowerLLLLLLLLLLLLLLLLLLLLLite).ppt
MyThaoAiDoan
 
xhgtccccccccccccccccccccccccccccc2).pptx
xhgtccccccccccccccccccccccccccccc2).pptxxhgtccccccccccccccccccccccccccccc2).pptx
xhgtccccccccccccccccccccccccccccc2).pptx
MyThaoAiDoan
 
2019-12-28 - TÌNH HÌNH SỨC KHỎE BỆNH TẬT TRẺ EM.pptx
2019-12-28 - TÌNH HÌNH SỨC KHỎE BỆNH TẬT TRẺ EM.pptx2019-12-28 - TÌNH HÌNH SỨC KHỎE BỆNH TẬT TRẺ EM.pptx
2019-12-28 - TÌNH HÌNH SỨC KHỎE BỆNH TẬT TRẺ EM.pptx
MyThaoAiDoan
 
viêm-phoi-cong-dongmmmmmmmmmmmmmmmm.pptx
viêm-phoi-cong-dongmmmmmmmmmmmmmmmm.pptxviêm-phoi-cong-dongmmmmmmmmmmmmmmmm.pptx
viêm-phoi-cong-dongmmmmmmmmmmmmmmmm.pptx
MyThaoAiDoan
 
nnnnnnnmmmmmmmmmmmmmmTHIEU VITAMIN A.ppt
nnnnnnnmmmmmmmmmmmmmmTHIEU VITAMIN  A.pptnnnnnnnmmmmmmmmmmmmmmTHIEU VITAMIN  A.ppt
nnnnnnnmmmmmmmmmmmmmmTHIEU VITAMIN A.ppt
MyThaoAiDoan
 
BỆNH CÒI XƯƠNG DO THIHHHẾU VITAMIN D.ppt
BỆNH CÒI XƯƠNG DO THIHHHẾU  VITAMIN D.pptBỆNH CÒI XƯƠNG DO THIHHHẾU  VITAMIN D.ppt
BỆNH CÒI XƯƠNG DO THIHHHẾU VITAMIN D.ppt
MyThaoAiDoan
 
BÀI-TIÊU-CHẢY-CCCCCCCCCCCCCCCCCCCCẤP.ppt
BÀI-TIÊU-CHẢY-CCCCCCCCCCCCCCCCCCCCẤP.pptBÀI-TIÊU-CHẢY-CCCCCCCCCCCCCCCCCCCCẤP.ppt
BÀI-TIÊU-CHẢY-CCCCCCCCCCCCCCCCCCCCẤP.ppt
MyThaoAiDoan
 
Acute Rheumatic Fevvvvvvvvvvvvvvvver.ppt
Acute Rheumatic Fevvvvvvvvvvvvvvvver.pptAcute Rheumatic Fevvvvvvvvvvvvvvvver.ppt
Acute Rheumatic Fevvvvvvvvvvvvvvvver.ppt
MyThaoAiDoan
 
CÁC THỜI KỲ CỦA TUỔI cccccTRẺ-after.pptx
CÁC THỜI KỲ CỦA TUỔI cccccTRẺ-after.pptxCÁC THỜI KỲ CỦA TUỔI cccccTRẺ-after.pptx
CÁC THỜI KỲ CỦA TUỔI cccccTRẺ-after.pptx
MyThaoAiDoan
 
NGHIÊN-CỨU-CẮT-NGANGGGGGGGGGGG-TỔ-5.pptx
NGHIÊN-CỨU-CẮT-NGANGGGGGGGGGGG-TỔ-5.pptxNGHIÊN-CỨU-CẮT-NGANGGGGGGGGGGG-TỔ-5.pptx
NGHIÊN-CỨU-CẮT-NGANGGGGGGGGGGG-TỔ-5.pptx
MyThaoAiDoan
 
GIAI_PHAU_DUONG_HO_HAP_-_TS_Hai_BMGPH_-29-7-2017_SVien_Modul_HoHap.pdf
GIAI_PHAU_DUONG_HO_HAP_-_TS_Hai_BMGPH_-29-7-2017_SVien_Modul_HoHap.pdfGIAI_PHAU_DUONG_HO_HAP_-_TS_Hai_BMGPH_-29-7-2017_SVien_Modul_HoHap.pdf
GIAI_PHAU_DUONG_HO_HAP_-_TS_Hai_BMGPH_-29-7-2017_SVien_Modul_HoHap.pdf
MyThaoAiDoan
 
CT_NGUC_BENH_LY_Y22222222222222_-_sv.pdf
CT_NGUC_BENH_LY_Y22222222222222_-_sv.pdfCT_NGUC_BENH_LY_Y22222222222222_-_sv.pdf
CT_NGUC_BENH_LY_Y22222222222222_-_sv.pdf
MyThaoAiDoan
 
Chuyen_cho_nnnnnnnnnnnnnnnnkhi_8-2017.pdf
Chuyen_cho_nnnnnnnnnnnnnnnnkhi_8-2017.pdfChuyen_cho_nnnnnnnnnnnnnnnnkhi_8-2017.pdf
Chuyen_cho_nnnnnnnnnnnnnnnnkhi_8-2017.pdf
MyThaoAiDoan
 
BAI_III_BENH_HOC_MO_KE_PHOI_MANG_PHOI.pdf
BAI_III_BENH_HOC_MO_KE_PHOI_MANG_PHOI.pdfBAI_III_BENH_HOC_MO_KE_PHOI_MANG_PHOI.pdf
BAI_III_BENH_HOC_MO_KE_PHOI_MANG_PHOI.pdf
MyThaoAiDoan
 
BAI_II_BENH_HkkkknkkkkOC_DUONG_HH_DUOI.pdf
BAI_II_BENH_HkkkknkkkkOC_DUONG_HH_DUOI.pdfBAI_II_BENH_HkkkknkkkkOC_DUONG_HH_DUOI.pdf
BAI_II_BENH_HkkkknkkkkOC_DUONG_HH_DUOI.pdf
MyThaoAiDoan
 
7_NHIEM_VI_NAM_HO_HApppppppppppppppP.pdf
7_NHIEM_VI_NAM_HO_HApppppppppppppppP.pdf7_NHIEM_VI_NAM_HO_HApppppppppppppppP.pdf
7_NHIEM_VI_NAM_HO_HApppppppppppppppP.pdf
MyThaoAiDoan
 
DAP_UNG_MIEN_DICH_CO_HAI_TRONG_BENH_NHIEM_VISINH_VAT.pdf
DAP_UNG_MIEN_DICH_CO_HAI_TRONG_BENH_NHIEM_VISINH_VAT.pdfDAP_UNG_MIEN_DICH_CO_HAI_TRONG_BENH_NHIEM_VISINH_VAT.pdf
DAP_UNG_MIEN_DICH_CO_HAI_TRONG_BENH_NHIEM_VISINH_VAT.pdf
MyThaoAiDoan
 

More from MyThaoAiDoan (20)

Chuyen de ung thuuuuuuuuuuuuuuuuuuuuuu.ppt
Chuyen de ung thuuuuuuuuuuuuuuuuuuuuuu.pptChuyen de ung thuuuuuuuuuuuuuuuuuuuuuu.ppt
Chuyen de ung thuuuuuuuuuuuuuuuuuuuuuu.ppt
 
Hoi chung lam sang benh ly gannnnnnn mat.ppt
Hoi chung lam sang benh ly gannnnnnn mat.pptHoi chung lam sang benh ly gannnnnnn mat.ppt
Hoi chung lam sang benh ly gannnnnnn mat.ppt
 
CHƯƠNG-TRÌNH-THỰC-TẬP-NHI-NĂM-THỨ-6-ĐỢT-1-2019-BV-NHI-ĐỒNG-2 (1).ppt
CHƯƠNG-TRÌNH-THỰC-TẬP-NHI-NĂM-THỨ-6-ĐỢT-1-2019-BV-NHI-ĐỒNG-2 (1).pptCHƯƠNG-TRÌNH-THỰC-TẬP-NHI-NĂM-THỨ-6-ĐỢT-1-2019-BV-NHI-ĐỒNG-2 (1).ppt
CHƯƠNG-TRÌNH-THỰC-TẬP-NHI-NĂM-THỨ-6-ĐỢT-1-2019-BV-NHI-ĐỒNG-2 (1).ppt
 
asd (NXPowerLLLLLLLLLLLLLLLLLLLLLite).ppt
asd (NXPowerLLLLLLLLLLLLLLLLLLLLLite).pptasd (NXPowerLLLLLLLLLLLLLLLLLLLLLite).ppt
asd (NXPowerLLLLLLLLLLLLLLLLLLLLLite).ppt
 
xhgtccccccccccccccccccccccccccccc2).pptx
xhgtccccccccccccccccccccccccccccc2).pptxxhgtccccccccccccccccccccccccccccc2).pptx
xhgtccccccccccccccccccccccccccccc2).pptx
 
2019-12-28 - TÌNH HÌNH SỨC KHỎE BỆNH TẬT TRẺ EM.pptx
2019-12-28 - TÌNH HÌNH SỨC KHỎE BỆNH TẬT TRẺ EM.pptx2019-12-28 - TÌNH HÌNH SỨC KHỎE BỆNH TẬT TRẺ EM.pptx
2019-12-28 - TÌNH HÌNH SỨC KHỎE BỆNH TẬT TRẺ EM.pptx
 
viêm-phoi-cong-dongmmmmmmmmmmmmmmmm.pptx
viêm-phoi-cong-dongmmmmmmmmmmmmmmmm.pptxviêm-phoi-cong-dongmmmmmmmmmmmmmmmm.pptx
viêm-phoi-cong-dongmmmmmmmmmmmmmmmm.pptx
 
nnnnnnnmmmmmmmmmmmmmmTHIEU VITAMIN A.ppt
nnnnnnnmmmmmmmmmmmmmmTHIEU VITAMIN  A.pptnnnnnnnmmmmmmmmmmmmmmTHIEU VITAMIN  A.ppt
nnnnnnnmmmmmmmmmmmmmmTHIEU VITAMIN A.ppt
 
BỆNH CÒI XƯƠNG DO THIHHHẾU VITAMIN D.ppt
BỆNH CÒI XƯƠNG DO THIHHHẾU  VITAMIN D.pptBỆNH CÒI XƯƠNG DO THIHHHẾU  VITAMIN D.ppt
BỆNH CÒI XƯƠNG DO THIHHHẾU VITAMIN D.ppt
 
BÀI-TIÊU-CHẢY-CCCCCCCCCCCCCCCCCCCCẤP.ppt
BÀI-TIÊU-CHẢY-CCCCCCCCCCCCCCCCCCCCẤP.pptBÀI-TIÊU-CHẢY-CCCCCCCCCCCCCCCCCCCCẤP.ppt
BÀI-TIÊU-CHẢY-CCCCCCCCCCCCCCCCCCCCẤP.ppt
 
Acute Rheumatic Fevvvvvvvvvvvvvvvver.ppt
Acute Rheumatic Fevvvvvvvvvvvvvvvver.pptAcute Rheumatic Fevvvvvvvvvvvvvvvver.ppt
Acute Rheumatic Fevvvvvvvvvvvvvvvver.ppt
 
CÁC THỜI KỲ CỦA TUỔI cccccTRẺ-after.pptx
CÁC THỜI KỲ CỦA TUỔI cccccTRẺ-after.pptxCÁC THỜI KỲ CỦA TUỔI cccccTRẺ-after.pptx
CÁC THỜI KỲ CỦA TUỔI cccccTRẺ-after.pptx
 
NGHIÊN-CỨU-CẮT-NGANGGGGGGGGGGG-TỔ-5.pptx
NGHIÊN-CỨU-CẮT-NGANGGGGGGGGGGG-TỔ-5.pptxNGHIÊN-CỨU-CẮT-NGANGGGGGGGGGGG-TỔ-5.pptx
NGHIÊN-CỨU-CẮT-NGANGGGGGGGGGGG-TỔ-5.pptx
 
GIAI_PHAU_DUONG_HO_HAP_-_TS_Hai_BMGPH_-29-7-2017_SVien_Modul_HoHap.pdf
GIAI_PHAU_DUONG_HO_HAP_-_TS_Hai_BMGPH_-29-7-2017_SVien_Modul_HoHap.pdfGIAI_PHAU_DUONG_HO_HAP_-_TS_Hai_BMGPH_-29-7-2017_SVien_Modul_HoHap.pdf
GIAI_PHAU_DUONG_HO_HAP_-_TS_Hai_BMGPH_-29-7-2017_SVien_Modul_HoHap.pdf
 
CT_NGUC_BENH_LY_Y22222222222222_-_sv.pdf
CT_NGUC_BENH_LY_Y22222222222222_-_sv.pdfCT_NGUC_BENH_LY_Y22222222222222_-_sv.pdf
CT_NGUC_BENH_LY_Y22222222222222_-_sv.pdf
 
Chuyen_cho_nnnnnnnnnnnnnnnnkhi_8-2017.pdf
Chuyen_cho_nnnnnnnnnnnnnnnnkhi_8-2017.pdfChuyen_cho_nnnnnnnnnnnnnnnnkhi_8-2017.pdf
Chuyen_cho_nnnnnnnnnnnnnnnnkhi_8-2017.pdf
 
BAI_III_BENH_HOC_MO_KE_PHOI_MANG_PHOI.pdf
BAI_III_BENH_HOC_MO_KE_PHOI_MANG_PHOI.pdfBAI_III_BENH_HOC_MO_KE_PHOI_MANG_PHOI.pdf
BAI_III_BENH_HOC_MO_KE_PHOI_MANG_PHOI.pdf
 
BAI_II_BENH_HkkkknkkkkOC_DUONG_HH_DUOI.pdf
BAI_II_BENH_HkkkknkkkkOC_DUONG_HH_DUOI.pdfBAI_II_BENH_HkkkknkkkkOC_DUONG_HH_DUOI.pdf
BAI_II_BENH_HkkkknkkkkOC_DUONG_HH_DUOI.pdf
 
7_NHIEM_VI_NAM_HO_HApppppppppppppppP.pdf
7_NHIEM_VI_NAM_HO_HApppppppppppppppP.pdf7_NHIEM_VI_NAM_HO_HApppppppppppppppP.pdf
7_NHIEM_VI_NAM_HO_HApppppppppppppppP.pdf
 
DAP_UNG_MIEN_DICH_CO_HAI_TRONG_BENH_NHIEM_VISINH_VAT.pdf
DAP_UNG_MIEN_DICH_CO_HAI_TRONG_BENH_NHIEM_VISINH_VAT.pdfDAP_UNG_MIEN_DICH_CO_HAI_TRONG_BENH_NHIEM_VISINH_VAT.pdf
DAP_UNG_MIEN_DICH_CO_HAI_TRONG_BENH_NHIEM_VISINH_VAT.pdf
 

Recently uploaded

Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
arahmanzai5
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
rightmanforbloodline
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 

Recently uploaded (20)

Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 

231115 Myocarditis - Duc Thhhang Y2.pptx

  • 2. CHIEF COMPLAINT A 22-year-old male patient presented to hospital because of his SOB
  • 3. DISCUSSION What additional information would you like to know?
  • 4. HISTORY OF PRESENT ILLNESS • Onset: 5 days prior to admission • Characteristic: both inhale and exhale, gradually progressive SOB • Exacerbating: Exertional, when pt have mild excertion • Relieving factor: take a rest • Associated symptoms: • No cough • No chest pain • Edema at both leg, fever 2 day resolved itself before edema happened Shortness of breath
  • 5. HISTORY 1. PMH: unremarkable 2. PSH: unremarkable 3. medication: None 4. Allergies: No allergic history 5. Social history: sexually active, No traveling recently, no alcohol intake, no smoking 6. Family history: unremarkable
  • 6. DISCUSSION On physical examination, what do you expect to find?
  • 7. PHYSICAL EXAMINATION • General status: alert and full of awareness, oriented x 3, No distress, no rash, BMI 21 • VS: Temp: 37 degree Celcius, HR: 115 bpm, BP: 130/75 mmHg, RR: 20 , SpO2 95-96% ambient air • HEENT: no abnormalities • CV: RRR, muffled heart sound ; systolic murmurs at 4th intercostal space left sternal edge, no rubs, or gallops, no jugular distention • Lungs: no wheezes, no rale, clear to percussion bilaterally, normal tactile fremitus. • Abdomen: no distention, soft, no tenderness. • Other organ : unremarkable finding
  • 9. ONE LINER A 22-years-old male patient with normal history presented to hospital because of his exertional SOB after 2 days of fever. On PE, he had edema and systolic murmur at mitral valve.
  • 10. DISCUSSION What is your differential diagnosis?
  • 11. DISCUSSION What tests would you like to order?
  • 12. LABORATORY AND IMAGING TEST CBC RBC 5.27 Hgb 162 g/L Hct 0.39 MCV 84 fL MCH 31 pg WBC 9.05 NEU 5.65 (62.4%) LYM 2.53 (28%) PLT 275 G/L Biochem – Electrolyte - Coagulation Natri 136.3 mmol/L Kali 3.4 mmol/L Clo 101 mmol/L Glucose 4.7 mmol/L CRP 1.9 ure 7.4 Tropoin Ths 422 NT-proBNP 6805 creatinin 71 AST 160 ALT 183 ABG Ph 7.5 HCO3 26.5 pCO2 34 PO2 Sa O2 Lactate 83 97% 1.4
  • 15. ECHOCARDIOGRAPHY • Pericardial effusion (7mm) • LV: Globally hypokinetic, dilation, EF 20% • Moderate mitral valve regurgitation • Mild aortic valve regurgitation • Mild pulmonary hypertension • Pleural effusion with small amount of fluid
  • 16. FINAL DIAGNOSIS Acute Heart Failure/ Acute Myocarditis
  • 17. Etiology of myocarditis Infectious causes Noninfectious causes Viral Spirochetal Cardiotoxins •Adenovirus •Arbovirus •Coxsackie B virus •Cytomegalovirus •Dengue •Echovirus •Epstein-Barr virus •Hepatitis B and C •Herpesvirus •HIV •Influenza A and B •Mumps •Parvovirus •Poliomyelitis •Rabies •Rubella •Rubeola •Vaccinia (smallpox vaccine) •Varicella •Variola •Yellow fever •Leptospirosis •Lyme disease •Relapsing fever •Syphilis •Alcohol •Anthracyclines •Arsenic •Carbon monoxide •Catecholamines •Cocaine •Cyclophosphamide •Heavy metals (copper, lead, iron) •Radiation Mycotic •Aspergillosis •Blastomycosis •Candidiasis •Coccidioidomycosis •Cryptococcosis •Histoplasmosis •Mucormycosis •Sporotrichosis Rickettsial Hypersensitivity reactions •Q fever •Rocky mountain spotted fever •Typhus •Antibiotics (penicillins, cephalosporins, sulfonamides) •Clozapine •Diuretics (thiazide, loop) •Dobutamine •Insect bites (bee, wasp, spider, scorpion) •Lithium •Methyldopa •Snake bites •Tetanus toxoid •Vaccinations (eg, vaccinia, coronavirus mRNA vaccines) Bacterial Protozoal Systemic disorders •Actinomycosis •Bartonella •Brucellosis •Chlamydia •Cholera •Clostridial •Diphtheria •Gonococcal •Haemophilus •Legionella •Meningococcal •Mycoplasma •Nocardia •Pneumococcal •Psittacosis •Salmonella •Staphylococcal •Streptococcal •Tetanus •Tuberculosis •Tularemia •Amebiasis •Chagas disease (South American trypanosomiasis) •Leishmaniasis •Malaria •Sleeping sickness (African trypanosomiasis) •Toxoplasmosis •Celiac disease •Collagen-vascular diseases •Granulomatosis with polyangiitis •Hypereosinophilia •Inflammatory bowel disease (Crohn disease, ulcerative colitis) •Kawasaki disease •Sarcoidosis •Thyrotoxicosis Helminthic •Ascariasis •Echinococcosis •Filariasis •Paragonimiasis •Schistosomiasis •Strongyloidiasis •Trichinosis Uptodate
  • 18. CLINICAL PRESENTATION • history of recent upper respiratory infection or enteritis • Excessive fatigue or exercise intolerance • Chest pain • Unexplained sinus tachycardia • S3, S4, or summation gallop • Atrial or ventricular arrhythmia • New-onset or worsening heart failure • Acute pericarditis • Sudden cardiac death • Respiratory distress/tachypnea • Hepatomegaly uptodate
  • 19. CLASSIFICATION uptodate Acute myocarditis Acute coronary syndrome- like New onset or worsening HF Life- threatening condition Chronic myocarditis Chronic active myocarditis Chronic persistent myocarditis
  • 20. ECG UPTODATE • ST changes • Single atrial or ventricular ectopic beats, • complex ventricular arrhythmias (couplets or nonsustained ventricular tachycardia), • atrial tachycardia or AF
  • 21. Endomyocardial Biopsy Histology + immunohistochemical stains (Dallas criteria): Gold standard -Definitive diagnosis of myocarditis uptodate
  • 22. Endomyocardial Biopsy EMB is recommended in the following settings: • unexplained fulminant HF • Unexplained new onset HF (2weeks-3 months) associated with a dilated LV and new ventricular arrhythmias, Mobitz type II second-degree AV block, third-degree AV block, or failure to respond to usual care within one to two weeks uptodate
  • 23. Endomyocardial Biopsy EMB is suggested in the following settings (when other evaluation is inconclusive): • HF of >3 months duration associated with dilated LV and new ventricular arrhythmias, second or third degree AV block, or failure to respond to usual care within one or two weeks • HF associated with dilated cardiomyopathy associated with suspected allergic reaction and/or eosinophilia. • Other specific clinical settings when other evaluation is inconclusive and diagnosis may impact treatment or prognosis uptodate
  • 25. “Clinically suspected myocarditis ” CRITERIA clinical presentation + noninvasive diagnostic findings abnormalities (CMR) uptodate identify patients who may be candidates for EMB - patients who do not have one indication for EMB - undergone EMB with nondiagnostic results WHEN TO APPLY CRITERIA
  • 26. Cardiovascular magnetic resonance (CMR) https://www.jacc.org/doi/10.1016/j.jacc.2021.01.043
  • 27. PCR and immunohistochemistry • "immunohistochemical criteria”: ≥14 leukocytes/mm2, including up to 4 monocytes/mm2 with the presence of CD3-positive T-lymphocytes ≥7 cells/mm2 • enteroviral genomes in the myocardium of HF patients were a biomarker of worse outcomes • persistence of viral genome by PCR was associated with progressive LV dysfunction, while clearance of viral genome was associated with improved LV function uptodate
  • 28. Management uptodate • Heart failure therapy • Therapy for arrhythmias GENERAL MANAGEMENT • Therapy for arrhythmias • Giant cell myocarditis • Eosinophilic myocarditis • Cardiac sarcoidosis • Treatment of non-viral infections • Celiac disease MANAGEMENT OF SPECIFIC DISORDERS
  • 29. TEACHING POINT • Suspect Myocarditis in patients with or without cardiac signs and symptoms , raised cardiac biomarkers, ECG changes suggestive of acute myocardial injury, arrhythmia, global/regional abnormalities of LV systolic function, particularly clinical findings are new and unexplained • Gold standard: EBM histology (Dallas criteria) +immunohistochemical stains • criteria for clinically suspected myocarditis: identify candidate for EBM or provide a clinical diagnosis for patients who do not have one indication for EMB
  • 30. Thank you for listening
  • 31. WHEN TO SUSPECT MYOCARDITIS?

Editor's Notes

  1.  Enlargement of the cardiac silhouette Phe huyet quan tang dam
  2. -a history of recent upper respiratory infection or enteritis was present in 36 percent of patients in a series of patients with biopsy-proven myocarditis The clinical manifestations of myocarditis are highly variable, ranging from subclinical disease to fatigue, chest pain, heart failure (HF), cardiogenic shock, arrhythmias, and sudden death
  3. Acute myocarditis has been defined as a condition with symptoms of HF developing over three months or less, while chronic myocarditis has been defined as developing over greater than three months  Acute coronary syndrome-like with acute chest pain in the absence of angiographic evidence of coronary artery disease (CAD): •Acute chest pain frequently starts within one to four weeks after a respiratory or gastrointestinal infection and is frequently associated with severe and recurrent symptoms.•ST/T wave changes include ST segment elevation or depression and T wave inversions.•Global or regional LV and/or RV dysfunction may or may not be detected.•Troponin T may or may not be elevated. The time course of troponin elevation may be similar to that with acute myocardial infarction (MI) or may be prolonged and sustained over several weeks or months. New onset or worsening HF New onset or progressive HF over two weeks to three months with symptoms including dyspnea, peripheral edema, chest discomfort, and fatigue.•Impaired LV and/or RV systolic function; the LV and/or RV may or may not be dilated and wall thicknesses may or may not be increased, as assessed by echocardiography or CMR. Some patients with ventricular dysfunction may progress to dilated cardiomyopathy. Symptoms may start after a respiratory or gastrointestinal infection or in the peripartum period. The electrocardiogram (ECG) may show non-specific changes, bundle branch block, atrioventricular (AV) block, or ventricular arrhythmias Life-threatening condition: Life-threatening arrhythmias and aborted sudden death, Cardiogenic shock, Severely impaired LV function chronic myocarditis : Some patients with myocarditis present with an indistinct onset of illness (ie, developing over more than three months), which has been described as subacute or chronic myocarditis.
  4. An ECG is not required to diagnose myocarditis but is generally obtained to exclude alternate causes of cardiac symptoms such as ischemia, to evaluate for arrhythmias, and to identify features (eg, high grade AV block) that may suggest certain causes of myocarditis. The ECG in patients with myocarditis may be normal or show nonspecific abnormalities. The ECG in some patients with myocarditis is similar to the ECG pattern of acute isolated pericarditis (which is suggestive of myopericarditis) or acute MI [6,26-29,40]. Like acute MI, myocarditis may be associated with regional ST elevations and Q waves. Myocarditis should be suspected in young patients who present with a possible MI but have a normal coronary angiogram High grade AV block is uncommon in lymphocytic myocarditis, but common in Lyme disease, cardiac sarcoidosis, and idiopathic giant cell myocarditis
  5. A definitive diagnosis of myocarditis is based upon identification of diagnostic findings on EMB, including histology (Dallas criteria) as well as immunohistochemical stains. When EMB findings are diagnostic, myocarditis is diagnosed even in the setting of concurrent heart disease, such as CAD IMAGING: Endomyocardial biopsy of the right ventricle showing acute diffuse myocarditis. There is prominent myofiber necrosis and loss in association with a high-grade mononuclear infiltrates
  6. Most patients presenting with subacute to chronic HF in whom a diagnosis of idiopathic dilated cardiomyopathy is made should first be managed with appropriate therapy for HF (see "Overview of the management of heart failure with reduced ejection fraction in adults"). Most of these patients will respond to medical therapy alone and do not require EMB.
  7. Dallas criteria — The Dallas criteria were developed by a panel of cardiac pathologists as a working standard for the United States Myocarditis Treatment Trial; these criteria are now used by most investigators to define the disease ●Active myocarditis is defined as "an inflammatory infiltrate of the myocardium with necrosis and/or degeneration of adjacent myocytes not typical of the ischemic damage associated with coronary artery disease." The infiltrates are usually mononuclear, but may be neutrophilic, or occasionally, eosinophilic ●"Borderline myocarditis" is the term used when the inflammatory infiltrate is too sparse or myocyte injury is not demonstrated.
  8. A combination of clinical presentation and noninvasive diagnostic findings including typical CMR abnormalities may be used to make a diagnosis of "clinically suspected" myocarditis. While histology remains the gold standard for establishing the diagnosis of myocarditis, low-risk patients may be diagnosed with "clinically suspected myocarditis" on the basis of a compatible clinical presentation When to apply criteria for clinically suspected myocarditis - To help identify patients who may be candidates for EMB - To provide a clinical diagnosis for patients who do not have one indication for EMB or who have undergone EMB with nondiagnostic results
  9. updated Lake Louise criteria were developed to incorporate T1 and T2 mapping and to enhance specificity compared to criteria requiring only a T1-based or a T2-based marker for myocarditis.
  10. "immunohistochemical criteria" for myocarditis to include an abnormal inflammatory infiltrate defined as ≥14 leukocytes/mm2, including up to 4 monocytes/mm2 with the presence of CD3-positive T-lymphocytes ≥7 cells/mm2
  11. Myocarditis should be suspected in patients with or without cardiac signs and symptoms (table 2), who have a rise in cardiac biomarkers (eg, troponin), ECG changes suggestive of acute myocardial injury, arrhythmia, or global or regional abnormalities of LV systolic function, particularly if the clinical findings are new and unexplained Clinical suspicion for myocarditis should be high in a patient who presents with clinical signs and symptoms of an acute MI, particularly if the patient lacks cardiovascular risk factors or the coronary angiogram is normal